{{Rsnum
|rsid=7212142
|Gene=RPTOR
|Chromosome=17
|position=80650141
|Orientation=plus
|GMAF=0.4555
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RPTOR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 13.3 | 50.4 | 36.3
| HCB | 10.9 | 40.9 | 48.2
| JPT | 6.2 | 40.7 | 53.1
| YRI | 71.9 | 26.0 | 2.1
| ASW | 54.4 | 43.9 | 1.8
| CHB | 10.9 | 40.9 | 48.2
| CHD | 7.4 | 38.9 | 53.7
| GIH | 9.9 | 49.5 | 40.6
| LWK | 64.5 | 30.9 | 4.5
| MEX | 5.2 | 39.7 | 55.2
| MKK | 52.6 | 39.7 | 7.7
| TSI | 16.7 | 51.0 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=19875696
|Title=Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}